Combination Rx/Device Products Should Have One FDA Filing, Wyeth Says
Executive Summary
Sponsors of combination drug/medical device products should not be required to submit two separate applications to FDA, Wyeth Associate Director-Regulatory Affairs Owen Fields, PhD, told an FDA public meeting on combination products Nov. 25